Abstract

Review Article

The Ketogenic Diet: The Ke(y) - to Success? A Review of Weight Loss, Lipids, and Cardiovascular Risk

Angela H Boal* and Christina Kanonidou

Published: 06 March, 2024 | Volume 9 - Issue 1 | Pages: 052-057

Background: Obesity remains a global epidemic with over 2.8 million people dying due to complications of being overweight or obese every year. The low-carbohydrate and high-fat ketogenic diet has a rising popularity for its rapid weight loss potential. However, most studies have a maximal 2-year follow-up, and therefore long-term adverse events remain unclear including the risk of Atherosclerotic Cardiovascular Disease (ASCVD).
Results: Based on current evidence on PubMed and Google Scholar, there is no strong indication ketogenic diet is advantageous for weight loss, lipid profile, and mortality. When comparing a hypocaloric ketogenic diet with a low-fat diet, there may be faster weight loss until 6 months, however, this then appears equivalent. Ketogenic diets have shown inconsistent Low-Density Lipoprotein (LDL) changes; perhaps from different saturated fat intake, dietary adherence, and genetics. Case reports have shown a 2-4-fold elevation in LDL in Familial hypercholesterolaemic patients which has mostly reversed upon dietary discontinuation. There is also concern about possible increased ASCVD and mortality: low (< 40%) carbohydrate intake has been associated with increased mortality, high LDL from saturated fats, high animal product consumption can increase trimethylamine N-oxide, and cardioprotective foods are likely minimally ingested.
Conclusion: Ketogenic diets have been associated with short-term positive effects including larger weight reductions. However, by 2 years there appears no significant differences for most cardiometabolic risk markers. Therefore, this raises the question, excluding those who have a critical need to lose weight fast, is this diet worth the potentially higher risks of ASCVD and mortality while further long-term studies are awaited?

Read Full Article HTML DOI: 10.29328/journal.jccm.1001178 Cite this Article Read Full Article PDF

Keywords:

Ketogenic; Obesity; Diet; Fat; Cholesterol; Cardiovascular disease; Low carbohydrate; Atherosclerosis

References

  1. World Health Organisation. Obesity and overweight. 2020. Accessed February 2024. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  2. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med. 2002 Sep 9;162(16):1867-72. doi: 10.1001/archinte.162.16.1867. PMID: 12196085.
  3. Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers (Basel). 2023 Jan 12;15(2):485. doi: 10.3390/cancers15020485. PMID: 36672434; PMCID: PMC9857053.
  4. Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity (Silver Spring). 2019 Jan;27(1):7-9. doi: 10.1002/oby.22378. PMID: 30569641.
  5. Masood W, Annamaraju P, Khan Suheb MZ, Uppaluri KR. Ketogenic Diet. 2023 Jun 16. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29763005.
  6. Höhn S, Dozières-Puyravel B, Auvin S. History of dietary treatment from Wilder's hypothesis to the first open studies in the 1920s. Epilepsy Behav. 2019 Dec;101(Pt A):106588. doi: 10.1016/j.yebeh.2019.106588. Epub 2019 Oct 30. PMID: 31677579.
  7. Evans M. Keto diets: good, bad or ugly? J Physiol. 2018 Oct;596(19):4561. doi: 10.1113/JP276703. Epub 2018 Aug 31. PMID: 30106483; PMCID: PMC6166066.
  8. Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013 Oct;110(7):1178-87. doi: 10.1017/S0007114513000548. Epub 2013 May 7. PMID: 23651522.
  9. Choi YJ, Jeon SM, Shin S. Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Nutrients. 2020; 12(7):2005.
  10. International Food Information Council. Food and Health Survey. 2023. Accessed February 2024. https://foodinsight.org/wp-content/uploads/2023/05/IFIC-2023-Food-Health-Report.pdf.
  11. Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, Accurso A, Frassetto L, Gower BA, McFarlane SI, Nielsen JV, Krarup T, Saslow L, Roth KS, Vernon MC, Volek JS, Wilshire GB, Dahlqvist A, Sundberg R, Childers A, Morrison K, Manninen AH, Dashti HM, Wood RJ, Wortman J, Worm N. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015 Jan;31(1):1-13. doi: 10.1016/j.nut.2014.06.011. Epub 2014 Jul 16. Erratum in: Nutrition. 2019 Jun;62:213. PMID: 25287761.
  12. Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, Veettil SK, Chaiyakunapruk N. Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials. BMC Med. 2023 May 25;21(1):196. doi: 10.1186/s12916-023-02874-y. PMID: 37231411; PMCID: PMC10210275.
  13. Miller VJ, Villamena FA, Volek JS. Nutritional Ketosis and Mitohormesis: Potential Implications for Mitochondrial Function and Human Health. J Nutr Metab. 2018 Feb 11;2018:5157645. doi: 10.1155/2018/5157645. PMID: 29607218; PMCID: PMC5828461.
  14. World Health Organisation. Healthy Diet. 2020. Accessed February 2024. https://www.who.int/news-room/fact-sheets/detail/healthy-diet.
  15. Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019 Nov;290:140-205. doi: 10.1016/j.atherosclerosis.2019.08.014. Epub 2019 Aug 31. Erratum in: Atherosclerosis. 2020 Jan;292:160-162. Erratum in: Atherosclerosis. 2020 Feb;294:80-82. PMID: 31591002.
  16. Public Health England. Eatwell Guide 2016. Accessed February 2024. https://assets.publishing.service.gov.uk/media/5bbb790de5274a22415d7fee/Eatwell_guide_colour_edition.pdf.
  17. Muscogiuri G, El Ghoch M, Colao A, Hassapidou M, Yumuk V, Busetto L; Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO). European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis. Obes Facts. 2021;14(2):222-245. doi: 10.1159/000515381. Epub 2021 Apr 21. PMID: 33882506; PMCID: PMC8138199.
  18. Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br J Nutr. 2016 Feb 14;115(3):466-79. doi: 10.1017/S0007114515004699. PMID: 26768850.
  19. Huntriss R, Campbell M, Bedwell C. The interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr. 2018 Mar;72(3):311-325. doi: 10.1038/s41430-017-0019-4. Epub 2017 Dec 21. PMID: 29269890.
  20. Rafiullah M, Musambil M, David SK. Effect of a very low-carbohydrate ketogenic diet vs recommended diets in patients with type 2 diabetes: a meta-analysis. Nutr Rev. 2022 Feb 10;80(3):488-502. doi: 10.1093/nutrit/nuab040. PMID: 34338787.
  21. Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, Willard KE, Maki KC. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. J Clin Lipidol. 2019 Sep-Oct;13(5):689-711.e1. doi: 10.1016/j.jacl.2019.08.003. Epub 2019 Sep 13. PMID: 31611148.
  22. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38. doi: 10.1161/01.cir.0000437739.71477.ee. Epub 2013 Nov 12. Erratum in: Circulation. 2014 Jun 24;129(25 Suppl 2):S139-40. PMID: 24222017; PMCID: PMC5819889.
  23. Vazquez-Vidal I, Desmarchelier C, Jones PJH. Nutrigenetics of Blood Cholesterol Concentrations: Towards Personalized Nutrition. Curr Cardiol Rep. 2019 Mar 29;21(5):38. doi: 10.1007/s11886-019-1124-x. PMID: 30927095.
  24. Jones PJ, Main BF, Frohlich JJ. Response of cholesterol synthesis to cholesterol feeding in men with different apolipoprotein E genotypes. Metabolism. 1993 Aug;42(8):1065-71. doi: 10.1016/0026-0495(93)90024-i. PMID: 8345812.
  25. Joo M, Moon S, Lee YS, Kim MG. Effects of very low-carbohydrate ketogenic diets on lipid profiles in normal-weight (body mass index < 25 kg/m2) adults: a meta-analysis. Nutr Rev. 2023 Oct 10;81(11):1393-1401. doi: 10.1093/nutrit/nuad017. PMID: 36931263.
  26. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation. 1997 Jan 7;95(1):69-75. doi: 10.1161/01.cir.95.1.69. PMID: 8994419.
  27. Akioyamen LE, Genest J, Shan SD, Reel RL, Albaum JM, Chu A, Tu JV. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017 Sep 1;7(9):e016461. doi: 10.1136/bmjopen-2017-016461. PMID: 28864697; PMCID: PMC5588988.
  28. Omar A, Fishberg R, Alam L. Ketogenic diets exacerbating hypercholesterolaemia in APOE variants and APOB mutations – potential role for measuring intestinal absorption of lipids. J Clin Lipidol. 2022; 16(3)e60-e61.
  29. Khovidhunkit W, Hanvivadhanakul P. Hypercholesterolemia exacerbated by a ketogenic diet. J Clin Lipidol. 2021 May-Jun;15(3):523-524. doi: 10.1016/j.jacl.2021.04.009. Epub 2021 May 7. PMID: 34030982.
  30. Houttu V, Grefhorst A, Cohn DM, Levels JHM, Roeters van Lennep J, Stroes ESG, Groen AK, Tromp TR. Severe Dyslipidemia Mimicking Familial Hypercholesterolemia Induced by High-Fat, Low-Carbohydrate Diets: A Critical Review. Nutrients. 2023 Feb 15;15(4):962. doi: 10.3390/nu15040962. PMID: 36839320; PMCID: PMC9964047.
  31. Hopkins PN, Wu LL, Hunt SC, Brinton EA. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol. 2005 Apr 5;45(7):1003-12. doi: 10.1016/j.jacc.2004.11.062. PMID: 15808755.
  32. Goldberg IJ, Ibrahim N, Bredefeld C, Foo S, Lim V, Gutman D, Huggins LA, Hegele RA. Ketogenic diets, not for everyone. J Clin Lipidol. 2021 Jan-Feb;15(1):61-67. doi: 10.1016/j.jacl.2020.10.005. Epub 2020 Oct 31. PMID: 33191194; PMCID: PMC7887024.
  33. Mahley RW, Huang Y, Rall SC Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999 Nov;40(11):1933-49. PMID: 10552997.
  34. Yang MU, Van Itallie TB. Composition of weight lost during short-term weight reduction. Metabolic responses of obese subjects to starvation and low-calorie ketogenic and nonketogenic diets. J Clin Invest. 1976 Sep;58(3):722-30. doi: 10.1172/JCI108519. PMID: 956398; PMCID: PMC333231.
  35. Gomez-Arbelaez D, Bellido D, Castro AI, Ordoñez-Mayan L, Carreira J, Galban C, Martinez-Olmos MA, Crujeiras AB, Sajoux I, Casanueva FF. Body Composition Changes After Very-Low-Calorie Ketogenic Diet in Obesity Evaluated by 3 Standardized Methods. J Clin Endocrinol Metab. 2017 Feb 1;102(2):488-498. doi: 10.1210/jc.2016-2385. PMID: 27754807.
  36. Krieger JW, Sitren HS, Daniels MJ, Langkamp-Henken B. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression 1. Am J Clin Nutr. 2006 Feb;83(2):260-74. doi: 10.1093/ajcn/83.2.260. PMID: 16469983.
  37. Adam-Perrot A, Clifton P, Brouns F. Low-carbohydrate diets: nutritional and physiological aspects. Obes Rev. 2006 Feb;7(1):49-58. doi: 10.1111/j.1467-789X.2006.00222.x. PMID: 16436102.
  38. Seidelmann SB, Claggett B, Cheng S, Henglin M, Shah A, Steffen LM, Folsom AR, Rimm EB, Willett WC, Solomon SD. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health. 2018 Sep;3(9):e419-e428. doi: 10.1016/S2468-2667(18)30135-X. Epub 2018 Aug 17. PMID: 30122560; PMCID: PMC6339822.
  39. Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies. J Am Heart Assoc. 2017 Jun 29;6(7):e004947. doi: 10.1161/JAHA.116.004947. PMID: 28663251; PMCID: PMC5586261.
  40. Tacconi E, Palma G, De Biase D, Luciano A, Barbieri M, de Nigris F, Bruzzese F. Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness-A Practical Preventing Recommendation and Therapies. Nutrients. 2023 Jan 21;15(3):563. doi: 10.3390/nu15030563. PMID: 36771270; PMCID: PMC9920414.
  41. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009 Feb 17;119(6):902-7. doi: 10.1161/CIRCULATIONAHA.108.191627. Epub 2009 Jan 26. PMID: 19171857.

Figures:

Similar Articles

Recently Viewed

  • Unusual and severe peripartum cardiomyopathy: A case report
    Lamanna B*, Vinciguerra M, Crupano FM, Cicinelli R, Cicinelli E and Vimercati A Lamanna B*,Vinciguerra M,Crupano FM,Cicinelli R,Cicinelli E,Vimercati A. Unusual and severe peripartum cardiomyopathy: A case report. J Cardiol Cardiovasc Med. 2021: doi: 10.29328/journal.jccm.1001116; 6: 040-043
  • Extracorporeal Membrane Oxygenation in Acute Aluminum Phosphide (AlP) Poisoning
    Oussama Ssouni*, Latifa Oualili, Tarek Dendane, Amine Ali Zeggwagh and Khalid Abidi Oussama Ssouni*, Latifa Oualili, Tarek Dendane, Amine Ali Zeggwagh, Khalid Abidi. Extracorporeal Membrane Oxygenation in Acute Aluminum Phosphide (AlP) Poisoning. Arch Surg Clin Res. 2023: doi: 10.29328/journal.ascr.1001071; 7: 024-034
  • Antibacterial Screening of Lippia origanoides Essential Oil on Gram-negative Bacteria
    Rodrigo Marcelino Zacarias de Andrade, Bernardina de Paixão Santos, Roberson Matteus Fernandes Silva, Mateus Gonçalves Silva*, Igor de Sousa Oliveira, Sávio Benvindo Ferreira and Rafaelle Cavalcante Lira Rodrigo Marcelino Zacarias de Andrade, Bernardina de Paixão Santos, Roberson Matteus Fernandes Silva, Mateus Gonçalves Silva*, Igor de Sousa Oliveira, Sávio Benvindo Ferreira, Rafaelle Cavalcante Lira. Antibacterial Screening of Lippia origanoides Essential Oil on Gram-negative Bacteria. Arch Pharm Pharma Sci. 2024: doi: 10.29328/journal.apps.1001053; 8: 024-028.
  • Systemic Lupus Erythematosus and Depression Overview
    Ahmed Shaaban*, Nourelhouda Said and Hoda Afifi Ahmed Shaaban*,Nourelhouda Said,Hoda Afifi. Systemic Lupus Erythematosus and Depression Overview. Insights Depress Anxiety. 2024: doi: 10.29328/journal.ida.1001039; 8: 001-004
  • Cytotoxic Effects of Aminotriles with Bioactive Potential: An Integrative Review
    Paola da Costa Vieira, Lettícia Tenório Cavalcanti, Hélida Maravilha Dantas e Sousa Almeida and Igor de Sousa Oliveira and Sávio Benvindo Ferreira* Paola da Costa Vieira, Lettícia Tenório Cavalcanti, Hélida Maravilha Dantas e Sousa Almeida, Igor de Sousa Oliveira and Sávio Benvindo Ferreira*. Cytotoxic Effects of Aminotriles with Bioactive Potential: An Integrative Review. Arch Pharm Pharma Sci. 2023: doi: 10.29328/journal.apps.1001040; 7: 022-027

Read More

Most Viewed

Read More

Help ?